Phase II Trial for the Treatment of Relapsed Osteosarcoma

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
Phase II randomized study for the comparison of the Gemcitabine plus Docetaxel and the Ifosfamide treatment of patients with relapsed osteosarcoma
Epistemonikos ID: 270b170930560dd14d96a26959dac8ca48daad8e
First added on: May 12, 2024